Aug 05, 2021 / 08:30PM GMT
Operator
Ladies and gentlemen, hello, and welcome to the Acorda Therapeutics Second Quarter 2021 Update. (Operator Instructions) I will now hand you over to your host, Tierney Saccavino, Executive Vice President of Corporate Communications at Acorda to begin. Tierney, please go ahead when you're ready.
Tierney Saccavino - Acorda Therapeutics, Inc. - EVP of Corporate Communications
Thank you, Maxine, and good afternoon, everyone.
Before we begin, let me remind you that our presentation will contain forward-looking statements. Detailed disclosures can be found in our SEC filings which are public, and we encourage you to refer to those filings. As a reminder to all callers, during the Q&A session, we will only take calls from our analysts. I'm now going to pass the call over to our CEO, Ron Cohen. Ron?
Ron Cohen - Acorda Therapeutics, Inc. - Founder, CEO, President & Director
Thanks, Tierney. Welcome, everyone. We'll get right into our report. I'm pleased to report that INBRIJA net revenue for the second quarter
Q2 2021 Acorda Therapeutics Inc Earnings Call Transcript
Feb 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers